UPMC Hillman Cancer Center

NCI-designated Comprehensive Cancer Center and a global leader in cancer research and cancer care affiliated with @PittTweet

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Join us in welcoming John C. Byrd, MD — our new director advancing discovery, improving cancer care, and changing lives @UPMC @PittTweet @PittHealthSci

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Thanks to everyone who came out last Thursday for Science, Chilled & Distilled; our speaker, Ron Buckanovich (@BuckanovichLab), who taught us about the importance of targeting slow growing cells to eliminate cancer; our community partner @PUMPpgh; and our host @EastEndBrewing!

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Join us this Thursday for Science, Chilled & Distilled @EastEndBrewing.

@PUMPpgh sat down with our speaker Dr. Ron Buckanovich (@BuckanovichLab) to hear what we can expect: https://t.co/jPJi82eEaP

🗓️ July 23 | 🕒 5:30 PM
📍 East End Brewing Company (147 Julius Street)

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Join us on July 23 at 5:30 PM for Science, Chilled & Distilled @EastEndBrewing (147 Julius Street) with Dr. Ron Buckanovich (@BuckanovichLab) who will share about his groundbreaking #ovariancancer research.

🔗More: https://t.co/Vy95PF3Fs8

@PUMPpgh

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Congratulations Dr. Laura De Castro (@ldc_paz) director of benign/heme at UPMC Hillman & Sickle Cell Disease Research Center of Excellence - named distinguished hematologist by @ASH_hematology!

[ASH @ASH_hematology]

ASH is proud to honor 11 distinguished hematologists with its most prestigious awards and named lectures, recognizing transformative contributions that have advanced research, patient care, and education in blood diseases.

🔗https://t.co/xNkJL1qT4l

#Hematology #ASHAwards

[UPMC Hillman Cancer Center @UPMCHillmanCC]

If you’re headed to the final day at #ASCO26…check out Dr Parham Habibzadeh’s (@HabibzadehMD) oral presentation on clonal hematopoiesis in identifying risk in developing #cancer. #cancerresearch
Wednesday| Jun 2| S100b| 9:45-12:45 @UPMCnews @PittHealthSci

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Happening now at #ASCO26. A packed house for several #melanoma studies including from Hillman’s Dr Diwakar Davar (@diwakardavar) @UPMCnews @PittHealthSci

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Be sure to check out Dr. Diwakar Davar (@diwakardavar) this morning at #ASCO26 presenting on next-gen TCR therapy showing significant response in adv. #melanoma & now heading to phase 3. @UPMCnews @PittHealthSci

[UPMC Hillman Cancer Center @UPMCHillmanCC]

#ASCO26 Merit awardee, Dr Matthew Nguyen @UPMCHeme_Onc talks about his oral presentation on a translational Phase lb/ll trial to improve immune response in #cancer. @RiyueSunnyBao @UPMCnews @PittHealthSci

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Rounding out morning posters at #ASCO26, Dr Michael Bishara-UPMC Harrisburg on promising efficacy w/taratamab in #SCLC. Poster 556. @UPMCnews @PittHealthSci

[UPMC Hillman Cancer Center @UPMCHillmanCC]

What if we could prevent #melanoma? @UPMCHillmanCC with @jmkirkwood & @PittHealthSci student Emma Kozuch presenting results of @eaonc open Ph 2 trial for melanoma prevention. See what it’s about #ASCO26 poster 487b. @UPMCnews

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Happening now @YanaNajjarMD presents Ph 3 trial on adv #melanoma that’s progressed on anti-PD-1 & anti-CTLA-4 therapy. Check it out! @UPMCnews @PittHealthSci

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Live now in the Airie Theater at #ASCO26 Dr Udai Kammula presents new information on #TIL therapy. @UPMCnews @pitt_immunology @PittHealthSci

[UPMC Hillman Cancer Center @UPMCHillmanCC]

A spirited debate underway #ASCO26 Rm 450b as Dr Alexander Olawaiye touts his belief that neoaduvant chemo before surgery in adv ovarian cancer is the way to go! Let’s see what the audience thinks! @MageeUroGyn @UPMCnews @PittHealthSci

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Coming up this morning #ASCO26 gyn/researcher Dr. Alexander Olawaiye talks neoadjuvant chemo in advanced #ovariancancer as he joins other experts in this ed session. @UPMCnews @MageeOBGYNRes @PittSurgOnc

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Check out new #immunotherapy reaearch presented by Dr Udai Kammula in an oral session at #ASCO26 coming up Sunday morning at 8 in Arie Crown Theater. @UPMCnews @pitt_immunology @PittHealthSci

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Afternoon poster session #ASCO26. Representing @UPMCHillmanCC @PittHealthSci & @MageeWomens is Jess Zheng/nutritional factors in H&N survival, Dr Josh Smith/lymphadenectomy in H&N and Dr Alexander Olawaiye/positive results of Phase 1 E7777 w/pembro in gyn malignancies.@UPMCnews

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Congratulations to our #ASCO26 awardees! Megan Hoang, Dr. Khvaramze Shaverdasvilli (@xako22) & Merit Award Winners, Dr. Parham Habibzadeh (@HabibzadehMD), Dr. Shravan Leonard-Murali & Dr. Matthew Nguyen. @UPMCnews @PittHealthSci @UPMCPhysicianEd

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Morning poster sessions underway at #ASCO26. @AnwaarSaeed3 on 2 studies on GI & #coloncancer - (bd 445b/Bd 175) Anushri Kulkarni on how diet affects immune therapy(Bd 269) -Dr Vince Reyes on IV vs subcutaneous immune therapy (Bd 595a). @UPMCnews @PittHealthSci @UPMCPhysicianEd

[UPMC Hillman Cancer Center @UPMCHillmanCC]

At #ASCO26 PD-1 & PD-L1 are widely used cancer therapies, but how long should patients remain on these? Dr Vince Reyes explains this recent @UPMCHillmanCC study. @UPMCnews @PittHealthSci @DanZandberg

[UPMC Hillman Cancer Center @UPMCHillmanCC]

Join @AnwaarSaeed3 at #ASCO26 this morning for 2 posters-expansion study of spevatamig as mono/combo for GI cancers (Bd175) & @NSABPFoundation (EMPIRE)-study of cemiplimab mono/combo therapy in #colorectalcancer (Bd445b) @UPMCnews @PittHealthSci